# Micron Technology Inc: financial statements, quarterly

MU · Nasdaq · CIK 723125 · [Technology](/sectors/technology.md) · fiscal year ends Sep 2

Pages: [Overview](/companies/mu.md) · [Financials](/companies/mu/financials.md) · [Filings](/companies/mu/filings.md) · [Insiders](/companies/mu/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mu/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-30) | Q4 FY2024 (2024-08-29) | Q1 FY2025 (2024-11-28) | Q2 FY2025 (2025-02-27) | Q3 FY2025 (2025-05-29) | Q4 FY2025 (2025-08-28) | Q1 FY2026 (2025-11-27) | Q2 FY2026 (2026-02-26) | Q3 FY2026 (2026-05-28) | Q4 FY2026 (2026-09-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [4.7](/filings/0000723125-24-000047.md) | [5.8](/filings/0000723125-25-000009.md) | [6.8](/filings/0000723125-25-000021.md) | [7.8 d](/filings/0000723125-26-000023.md) | [8.7](/filings/0000723125-25-000046.md) | [8.1](/filings/0000723125-26-000006.md) | [9.3](/filings/0000723125-26-000015.md) | [11.3 d](/filings/0000723125-26-000023.md) | [13.6](/filings/0000723125-25-000046.md) | [23.9](/filings/0000723125-26-000006.md) | [41.5](/filings/0000723125-26-000015.md) | [54.2 d](/filings/0000723125-26-000023.md) |
| Cost of revenue | $bn | [4.8](/filings/0000723125-24-000047.md) | [4.7](/filings/0000723125-25-000009.md) | [5.0](/filings/0000723125-25-000021.md) | [5.0 d](/filings/0000723125-26-000023.md) | [5.4](/filings/0000723125-25-000046.md) | [5.1](/filings/0000723125-26-000006.md) | [5.8](/filings/0000723125-26-000015.md) | [6.3 d](/filings/0000723125-26-000023.md) | [6.0](/filings/0000723125-25-000046.md) | [6.1](/filings/0000723125-26-000006.md) | [6.4](/filings/0000723125-26-000015.md) | [7.2 d](/filings/0000723125-26-000023.md) |
| Gross profit | $bn | [(0.0)](/filings/0000723125-24-000047.md) | [1.1](/filings/0000723125-25-000009.md) | [1.8](/filings/0000723125-25-000021.md) | [2.7 d](/filings/0000723125-26-000023.md) | [3.3](/filings/0000723125-25-000046.md) | [3.0](/filings/0000723125-26-000006.md) | [3.5](/filings/0000723125-26-000015.md) | [5.1 d](/filings/0000723125-26-000023.md) | [7.6](/filings/0000723125-25-000046.md) | [17.8](/filings/0000723125-26-000006.md) | [35.1](/filings/0000723125-26-000015.md) | [47.0 d](/filings/0000723125-26-000023.md) |
| Research and development | $bn | [0.8](/filings/0000723125-24-000047.md) | [0.8](/filings/0000723125-25-000009.md) | [0.9](/filings/0000723125-25-000021.md) | [0.9 d](/filings/0000723125-26-000023.md) | [0.9](/filings/0000723125-25-000046.md) | [0.9](/filings/0000723125-26-000006.md) | [1.0](/filings/0000723125-26-000015.md) | [1.0 d](/filings/0000723125-26-000023.md) | [1.2](/filings/0000723125-25-000046.md) | [1.3](/filings/0000723125-26-000006.md) | [1.3](/filings/0000723125-26-000015.md) | [1.9 d](/filings/0000723125-26-000023.md) |
| Selling, general and administrative | $bn | [0.3](/filings/0000723125-24-000047.md) | [0.3](/filings/0000723125-25-000009.md) | [0.3](/filings/0000723125-25-000021.md) | [0.3 d](/filings/0000723125-26-000023.md) | [0.3](/filings/0000723125-25-000046.md) | [0.3](/filings/0000723125-26-000006.md) | [0.3](/filings/0000723125-26-000015.md) | [0.3 d](/filings/0000723125-26-000023.md) | [0.3](/filings/0000723125-25-000046.md) | [0.3](/filings/0000723125-26-000006.md) | [0.4](/filings/0000723125-26-000015.md) | [0.9 d](/filings/0000723125-26-000023.md) |
| Operating income | $bn | [(1.1)](/filings/0000723125-24-000047.md) | [0.2](/filings/0000723125-25-000009.md) | [0.7](/filings/0000723125-25-000021.md) | [1.5 d](/filings/0000723125-26-000023.md) | [2.2](/filings/0000723125-25-000046.md) | [1.8](/filings/0000723125-26-000006.md) | [2.2](/filings/0000723125-26-000015.md) | [3.7 d](/filings/0000723125-26-000023.md) | [6.1](/filings/0000723125-25-000046.md) | [16.1](/filings/0000723125-26-000006.md) | [33.3](/filings/0000723125-26-000015.md) | [43.8 d](/filings/0000723125-26-000023.md) |
| Interest expense | $bn | [0.1](/filings/0000723125-23-000077.md) | [0.1](/filings/0000723125-24-000007.md) | [0.2](/filings/0000723125-24-000019.md) | [0.1 d](/filings/0000723125-26-000023.md) | [0.1](/filings/0000723125-25-000046.md) | [0.1](/filings/0000723125-26-000006.md) | [0.1](/filings/0000723125-26-000015.md) | [0.1 d](/filings/0000723125-26-000023.md) | [0.1](/filings/0000723125-25-000046.md) | [0.0](/filings/0000723125-26-000006.md) | [0.0](/filings/0000723125-26-000015.md) | [0.0 d](/filings/0000723125-26-000023.md) |
| Income tax | $bn | [0.1](/filings/0000723125-24-000047.md) | [(0.6)](/filings/0000723125-25-000009.md) | [0.4](/filings/0000723125-25-000021.md) | [0.6 d](/filings/0000723125-26-000023.md) | [0.3](/filings/0000723125-25-000046.md) | [0.2](/filings/0000723125-26-000006.md) | [0.2](/filings/0000723125-26-000015.md) | [0.4 d](/filings/0000723125-26-000023.md) | [0.8](/filings/0000723125-25-000046.md) | [2.4](/filings/0000723125-26-000006.md) | [5.0](/filings/0000723125-26-000015.md) | [6.6 d](/filings/0000723125-26-000023.md) |
| Net income | $bn | [(1.2)](/filings/0000723125-25-000021.md) | [0.8](/filings/0000723125-25-000021.md) | [0.3](/filings/0000723125-25-000021.md) | [0.9 d](/filings/0000723125-26-000023.md) | [1.9](/filings/0000723125-25-000046.md) | [1.6](/filings/0000723125-26-000006.md) | [1.9](/filings/0000723125-26-000015.md) | [3.2 d](/filings/0000723125-26-000023.md) | [5.2](/filings/0000723125-25-000046.md) | [13.8](/filings/0000723125-26-000006.md) | [28.2](/filings/0000723125-26-000015.md) | [37.7 d](/filings/0000723125-26-000023.md) |
| Diluted EPS | $ per share | [(1.12)](/filings/0000723125-24-000047.md) | [0.71](/filings/0000723125-25-000009.md) | [0.30](/filings/0000723125-25-000021.md) | not reported | [1.67](/filings/0000723125-25-000046.md) | [1.41](/filings/0000723125-26-000006.md) | [1.68](/filings/0000723125-26-000015.md) | not reported | [4.60](/filings/0000723125-25-000046.md) | [12.07](/filings/0000723125-26-000006.md) | [24.67](/filings/0000723125-26-000015.md) | not reported |
| Basic EPS | $ per share | [(1.12)](/filings/0000723125-24-000047.md) | [0.72](/filings/0000723125-25-000009.md) | [0.30](/filings/0000723125-25-000021.md) | not reported | [1.68](/filings/0000723125-25-000046.md) | [1.42](/filings/0000723125-26-000006.md) | [1.69](/filings/0000723125-26-000015.md) | not reported | [4.66](/filings/0000723125-25-000046.md) | [12.25](/filings/0000723125-26-000006.md) | [25.03](/filings/0000723125-26-000015.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-30) | FY2024 (2024-08-29) | Q1 FY2025 (2024-11-28) | Q2 FY2025 (2025-02-27) | Q3 FY2025 (2025-05-29) | FY2025 (2025-08-28) | Q1 FY2026 (2025-11-27) | Q2 FY2026 (2026-02-26) | Q3 FY2026 (2026-05-28) | FY2026 (2026-09-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [8.1](/filings/0000723125-23-000077.md) | [8.0](/filings/0000723125-24-000007.md) | [7.6](/filings/0000723125-24-000019.md) | [7.0](/filings/0000723125-25-000028.md) | [6.7](/filings/0000723125-24-000047.md) | [7.6](/filings/0000723125-25-000009.md) | [10.2](/filings/0000723125-25-000021.md) | [9.6](/filings/0000723125-26-000023.md) | [9.7](/filings/0000723125-25-000046.md) | [13.9](/filings/0000723125-26-000006.md) | [25.0](/filings/0000723125-26-000015.md) | [38.4](/filings/0000723125-26-000023.md) |
| Current assets | $bn | [21.1](/filings/0000723125-23-000077.md) | [23.4](/filings/0000723125-24-000007.md) | [23.3](/filings/0000723125-24-000019.md) | [24.4](/filings/0000723125-25-000028.md) | [24.5](/filings/0000723125-24-000047.md) | [24.7](/filings/0000723125-25-000009.md) | [27.9](/filings/0000723125-25-000021.md) | [28.8](/filings/0000723125-26-000023.md) | [29.7](/filings/0000723125-25-000046.md) | [41.4](/filings/0000723125-26-000006.md) | [66.7](/filings/0000723125-26-000015.md) | [91.1](/filings/0000723125-26-000023.md) |
| Total assets | $bn | [63.8](/filings/0000723125-23-000077.md) | [65.7](/filings/0000723125-24-000007.md) | [66.3](/filings/0000723125-24-000019.md) | [69.4](/filings/0000723125-25-000028.md) | [71.5](/filings/0000723125-24-000047.md) | [73.1](/filings/0000723125-25-000009.md) | [78.4](/filings/0000723125-25-000021.md) | [82.8](/filings/0000723125-26-000023.md) | [86.0](/filings/0000723125-25-000046.md) | [102](/filings/0000723125-26-000006.md) | [134](/filings/0000723125-26-000015.md) | [196](/filings/0000723125-26-000023.md) |
| Current liabilities | $bn | [6.0](/filings/0000723125-23-000077.md) | [6.3](/filings/0000723125-24-000007.md) | [6.8](/filings/0000723125-24-000019.md) | [9.2](/filings/0000723125-25-000028.md) | [9.0](/filings/0000723125-24-000047.md) | [7.9](/filings/0000723125-25-000009.md) | [10.1](/filings/0000723125-25-000021.md) | [11.5](/filings/0000723125-26-000023.md) | [12.1](/filings/0000723125-25-000046.md) | [14.3](/filings/0000723125-26-000006.md) | [19.5](/filings/0000723125-26-000015.md) | [27.5](/filings/0000723125-26-000023.md) |
| Total liabilities | $bn | [20.9](/filings/0000723125-23-000077.md) | [21.8](/filings/0000723125-24-000007.md) | [22.0](/filings/0000723125-24-000019.md) | [24.3](/filings/0000723125-25-000028.md) | [24.7](/filings/0000723125-24-000047.md) | [24.4](/filings/0000723125-25-000009.md) | [27.6](/filings/0000723125-25-000021.md) | [28.6](/filings/0000723125-26-000023.md) | [27.2](/filings/0000723125-25-000046.md) | [29.1](/filings/0000723125-26-000006.md) | [33.4](/filings/0000723125-26-000015.md) | [57.5](/filings/0000723125-26-000023.md) |
| Long-term debt | $bn | [12.0](/filings/0000723125-23-000077.md) | [12.0](/filings/0000723125-24-000007.md) | [11.3](/filings/0000723125-24-000019.md) | [11.3](/filings/0000723125-24-000027.md) | [11.3](/filings/0000723125-24-000047.md) | [11.5](/filings/0000723125-25-000009.md) | [12.4](/filings/0000723125-25-000021.md) | [11.5](/filings/0000723125-25-000028.md) | [8.8](/filings/0000723125-25-000046.md) | not reported | not reported | [2.8](/filings/0000723125-26-000023.md) |
| Current portion of debt | $bn | [0.9](/filings/0000723125-23-000077.md) | [0.3](/filings/0000723125-24-000007.md) | [0.4](/filings/0000723125-24-000019.md) | [0.4](/filings/0000723125-25-000028.md) | [0.5](/filings/0000723125-24-000047.md) | [0.5](/filings/0000723125-25-000009.md) | [0.5](/filings/0000723125-25-000021.md) | [0.6](/filings/0000723125-26-000023.md) | [0.6](/filings/0000723125-25-000046.md) | [0.6](/filings/0000723125-26-000006.md) | [0.6](/filings/0000723125-26-000015.md) | [0.5](/filings/0000723125-26-000023.md) |
| Shareholders' equity | $bn | [42.9](/filings/0000723125-25-000021.md) | [43.9](/filings/0000723125-25-000021.md) | [44.2](/filings/0000723125-25-000021.md) | [45.1](/filings/0000723125-26-000023.md) | [46.8](/filings/0000723125-26-000006.md) | [48.6](/filings/0000723125-26-000015.md) | [50.7](/filings/0000723125-26-000015.md) | [54.2](/filings/0000723125-26-000023.md) | [58.8](/filings/0000723125-26-000006.md) | [72.5](/filings/0000723125-26-000015.md) | [101](/filings/0000723125-26-000015.md) | [138](/filings/0000723125-26-000023.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-30) | Q4 FY2024 (2024-08-29) | Q1 FY2025 (2024-11-28) | Q2 FY2025 (2025-02-27) | Q3 FY2025 (2025-05-29) | Q4 FY2025 (2025-08-28) | Q1 FY2026 (2025-11-27) | Q2 FY2026 (2026-02-26) | Q3 FY2026 (2026-05-28) | Q4 FY2026 (2026-09-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $bn | [1.4](/filings/0000723125-24-000047.md) | [1.2 d](/filings/0000723125-25-000009.md) | [2.5 d](/filings/0000723125-25-000021.md) | [3.4 d](/filings/0000723125-26-000023.md) | [3.2](/filings/0000723125-25-000046.md) | [3.9 d](/filings/0000723125-26-000006.md) | [4.6 d](/filings/0000723125-26-000015.md) | [5.7 d](/filings/0000723125-26-000023.md) | [8.4](/filings/0000723125-25-000046.md) | [11.9 d](/filings/0000723125-26-000006.md) | [25.4 d](/filings/0000723125-26-000015.md) | [44.0 d](/filings/0000723125-26-000023.md) |
| Capital expenditure | $bn | [1.8](/filings/0000723125-24-000047.md) | [1.4 d](/filings/0000723125-25-000009.md) | [2.1 d](/filings/0000723125-25-000021.md) | [3.1 d](/filings/0000723125-26-000023.md) | [3.2](/filings/0000723125-25-000046.md) | [4.1 d](/filings/0000723125-26-000006.md) | [2.9 d](/filings/0000723125-26-000015.md) | [5.7 d](/filings/0000723125-26-000023.md) | [5.4](/filings/0000723125-25-000046.md) | [6.4 d](/filings/0000723125-26-000006.md) | [7.8 d](/filings/0000723125-26-000015.md) | [11.1 d](/filings/0000723125-26-000023.md) |
| Dividends paid | $bn | [0.1](/filings/0000723125-24-000047.md) | [0.1](/filings/0000723125-24-000019.md) | [0.1](/filings/0000723125-24-000019.md) | [0.1 d](/filings/0000723125-26-000023.md) | [0.1](/filings/0000723125-25-000046.md) | [0.1 d](/filings/0000723125-26-000006.md) | [0.1 d](/filings/0000723125-26-000015.md) | [0.1 d](/filings/0000723125-26-000023.md) | [0.1](/filings/0000723125-25-000046.md) | [0.1 d](/filings/0000723125-26-000006.md) | [0.2 d](/filings/0000723125-26-000015.md) | [0.2 d](/filings/0000723125-26-000023.md) |
| Share repurchases | $bn | [0.0](/filings/0000723125-23-000077.md) | [0.0 d](/filings/0000723125-24-000007.md) | [0.0 d](/filings/0000723125-24-000019.md) | [0.3 d](/filings/0000723125-26-000023.md) | [0.0](/filings/0000723125-25-000046.md) | [0.0 d](/filings/0000723125-26-000006.md) | [0.0 d](/filings/0000723125-26-000015.md) | [0.0 d](/filings/0000723125-26-000023.md) | [0.3](/filings/0000723125-25-000046.md) | [0.4 d](/filings/0000723125-26-000006.md) | [0.0 d](/filings/0000723125-26-000015.md) | [0.0 d](/filings/0000723125-26-000023.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-01) | Q2 FY2023 (2023-03-02) | Q3 FY2023 (2023-06-01) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-30) | Q1 FY2025 (2024-11-28) | Q2 FY2025 (2025-02-27) | Q3 FY2025 (2025-05-29) | Q1 FY2026 (2025-11-27) | Q2 FY2026 (2026-02-26) | Q3 FY2026 (2026-05-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,090](/filings/0000723125-23-000077.md) | [1,091](/filings/0000723125-24-000007.md) | [1,094](/filings/0000723125-24-000019.md) | [1,100](/filings/0000723125-24-000047.md) | [1,114](/filings/0000723125-25-000009.md) | [1,123](/filings/0000723125-25-000021.md) | [1,122](/filings/0000723125-25-000046.md) | [1,123](/filings/0000723125-26-000006.md) | [1,125](/filings/0000723125-26-000015.md) | [1,138](/filings/0000723125-25-000046.md) | [1,142](/filings/0000723125-26-000006.md) | [1,145](/filings/0000723125-26-000015.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,131,423,212 at 2026-10-02, from the cover of the [10-K filed 2026-10-09](/filings/0000723125-26-000023.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.